Diagnosis

Exome sequencing: potential diagnostic assay for unexplained intellectual disability, scientists report at ASHG 2012

Exome sequencing: potential diagnostic assay for unexplained intellectual disability, scientists report at ASHG 2012

NEWS For more information: Cathy Yarbrough press@ashg.org 858-243-1814 Embargo: 10:30 a.m. PT, Thursday, Nov. 8, 2012 Research findings confirming that de novo mutations represent a major cause of previously unexplained intellectual disability were presented today (Nov. 8) at the American Society of Human Genetics 2012 meeting in San Francisco. Josep de Ligt, M.Sc., bioinformatician and... Read More

Addressing Tandem MS in Newborn Screening

Addressing Tandem MS in Newborn Screening

ASHG and the American College of Medical Genetics issued a 2000 statement describing tandem mass spectrometry and its potential role in newborn screening programs. The statement describes the state of the science as well as questions to be considered in its implementation, including funding and training. Related: Statement on Tandem Mass Spectrometry in Newborn Screening... Read More

ASHG uses cookies to provide you with a secure and custom web experience. Privacy Policy